HRSA-24-047: State Maternal Health Innovation
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2023.
Health Resources and Services Administration offered grants to nonprofits, state and local governments, tribes, small businesses and businesses. It expected to make about 18 awards worth $18.0 million in total. Applications closed on April 2, 2024.
From the official notice on Grants.gov, last changed December 18, 2023. Checked November 7, 2026.
- Total funding$18.0 million
- Expected awards18
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | December 15, 2023 |
|---|---|
| Deadline | April 2, 2024 |
Who can apply
This opportunity was open to nonprofits, state and local governments, tribes, small businesses and businesses.
All 11 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
You can apply if your organization is in the United States and is: Public or private, non-profit Community-based Tribal (governments, organizations)
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the State Maternal Health Innovation (State MHI) program. The purpose of the State MHI program is to reduce maternal mortality and severe maternal morbidity (SMM)3 by: • Improving access to care that is comprehensive, high-quality, appropriate, and on-going throughout the preconception, prenatal, labor and delivery, and postpartum periods; • Enhancing state maternal health surveillance and data capacity; and • Identifying and implementing innovative interventions to improve outcomes for populations disproportionately impacted by maternal mortality and SMM. The program objectives to be accomplished during the period of performance to support programs goals, are: • By September 29, 2025 (Project Year 1), each recipient will develop a draft 5-Year Maternal Health Strategic Plan (MHSP) to improve maternal health. • By September 29, 2025 (Year 1), award recipients will identify core measures to assess and report on program activities, including innovations, throughout the period of performance. This will take place in collaboration with HRSA. • By September 29, 2026 (Year 2), each recipient and their established MHTF will submit a final MHSP. • By September 29, 2029 (Year 5), each recipient will increase the number of community members from populations with the highest rates of maternal mortality and severe maternal morbidity that participate on the state's Maternal Health Task Force and in the implementation of the MHSP activities. • Recipients will release a public Maternal Health Annual Report each year of the period of performance about maternal health topics relevant to the state. • By September 29, 2029 (Year 5), identify and share the innovations with potential for replication, scale-up, and sustainability to improve maternal health. For more details, see Program Requirements and Expectations. MCH MCHB
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-24-047 still open?
No. It closed on April 2, 2024. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for State Maternal Health Innovation?
Health Resources and Services Administration accepted applications from nonprofits, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for State Maternal Health Innovation?
Closed April 2, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $18.0 million in total across about 18 awards.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)